Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galectin Therapeutics Inc. - Common Stock (NQ:GALT)

1.385 +0.005 (+0.36%)
Streaming Delayed Price Updated: 3:09 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Galectin Therapeutics Inc. - Common Stock

< Previous 1 2 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Dow Surges Over 600 Points, Gold Jumps 1.5%
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
Via Benzinga
Dow Surges 100 Points, Carnival Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday?
Galectin Therapeutics' NAVIGATE trial shows belapectin reduces varices in MASH cirrhosis, but falls short of statistical targets; full data due in early 2025. 
Via Benzinga
Galectin Therapeutics: Q3 Earnings Insights
Via Benzinga
Recap: Galectin Therapeutics Q1 Earnings
Galectin Therapeutics (NASDAQ:GALT) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
GALT stock results show that Galectin Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
Via The Motley Fool
More Personal Portfolio: Biotech, Commodities, And Gold
In a few years we will know if that was an extraordinarily opportunistic moment, or a long and frustrating rabbit hole. 
Via Talk Markets
Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
7 Short-Interest Stocks to Target for Explosive Gains
For contrarian investors that can stand the heat, short-interest stocks to buy can offer significant rewards in a short time period. 
Via InvestorPlace
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Around $30 Million Bet On This Communication Services Stock? 4 Penny Stocks Insiders Are Buying
The Dow Jones gained by more than 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers for investors to keep an eye on today! 
Via InvestorPlace
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 78 companies set new 52-week lows. Key Facts About Today's 52-Week Lows: Citigroup (NYSE:C) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
Galectin Therapeutics: Q4 Earnings Insights
  Galectin Therapeutics (NASDAQ:GALT) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.